Andrew Ritter, CEO & President, Director at Qualigen Therapeutics, holds 82.35K shares in Qualigen Therapeutics (Ticker: QLGN). Most recently, Andrew Ritter Sold $18,750 shares of Qualigen Therapeutics on Mar 13, 2020 for an estimated value of 6.94K.